Clinical Trials Using BET Bromodomain Inhibitor ZEN-3694
Clinical trials are research studies that involve people. The clinical trials on this list are studying BET Bromodomain Inhibitor ZEN-3694. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
This is two-part open label, non-randomized, Phase 2, study of ZEN003694 in combination with Talazoparib in patients with TNBC without germline mutations of BRCA1 or BRCA2. Part 1 is dose escalation and Part 2 is a Simon 2-Stage design
Location: 2 locations